Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Recruiting · NCT04680442 · Registry updated 2025-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-04-06 | NCT04680442 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Population Health Research Institute | 43 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clínica de Pesquisa e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda | São Paulo | Brazil | 1 |
| E.Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation | Novosibirsk | Russia | 2 |
| Hospital Alemão Oswaldo Cruz | São Paulo | Brazil | 1 |
| Hospital de Clínicas de Porto Alegre | Porto Alegre | Brazil | 1 |
| Irmandade da Santa Casa de Misericórdia de Porto Alegre | Porto Alegre | Brazil | 5 |
| Juravnski Cancer Centre | Hamitlon | Canada | 1 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 5 |
| Toronto General Hospital, University Health Network | Toronto | Canada | 1 |